JNGLX
Price
$68.49
Change
+$0.92 (+1.36%)
Updated
Aug 15 closing price
Net Assets
4.28B
LHCFX
Price
$19.40
Change
+$0.12 (+0.62%)
Updated
Aug 15 closing price
Net Assets
7.55M
Interact to see
Advertisement

JNGLX vs LHCFX

Header iconJNGLX vs LHCFX Comparison
Open Charts JNGLX vs LHCFXBanner chart's image
Janus Henderson Global Life Sciences D
Price$68.49
Change+$0.92 (+1.36%)
VolumeN/A
Net Assets4.28B
Lord Abbett Health Care F
Price$19.40
Change+$0.12 (+0.62%)
VolumeN/A
Net Assets7.55M
JNGLX vs LHCFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JNGLX vs. LHCFX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Buy and LHCFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.29B vs. LHCFX (7.55M). LHCFX pays higher dividends than JNGLX: LHCFX (0.48) vs JNGLX (0.36). JNGLX was incepted earlier than LHCFX: JNGLX (27 years) vs LHCFX (6 years). LHCFX (3.19) is less costly to investors than JNGLX (0.80). LHCFX is a more actively managed with annual turnover of: 88.00 vs. JNGLX (35.00). LHCFX has a lower initial minimum investment than JNGLX: LHCFX (0) vs JNGLX (2500). LHCFX annual gain was more profitable for investors over the last year : -4.73 vs. JNGLX (-14.24). LHCFX return over 5 years is better than : 5.77 vs. JNGLX (5.06).
JNGLXLHCFXJNGLX / LHCFX
Total Expense Ratio0.800.78103%
Annual Report Gross Expense Ratio0.803.1925%
Fund Existence27 years6 years-
Gain YTD0.8840.000-
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.29B7.55M56,770%
Annual Yield % from dividends0.360.4875%
Returns for 1 year-14.24-4.73301%
Returns for 3 years6.217.8879%
Returns for 5 years5.065.7788%
Returns for 10 years12.18N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLC0.05N/A
+1.64%
Oncotelic Therapeutics, Inc.
APMSF30.50N/A
N/A
Aperam S.A.
AILIM76.25N/A
N/A
Ameren Illinois Company
GRPTF19.28N/A
N/A
Getlink SE
MLGF20.16-0.02
-0.10%
Malaga Financial Corp.